Previous close | 1.2800 |
Open | 1.2800 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 7.50 |
Expiry date | 2024-08-16 |
Day's range | 1.2800 - 1.2800 |
Contract range | N/A |
Volume | |
Open interest | 2 |
GOLETA, Calif., July 03, 2024--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex Medical, where he served as General Counsel and Executive Vice President, Business Development, since 2018.
KARL STORZ is set to acquire all of the outstanding shares of Asensus Surgical (ASXC) for $0.35 per share in cash, making Asensus a subsidiary of KARL STORZ.
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.